Beyond-the-Needle Initiative of Nano PharmaSolutions for Fighting COVID-19
Nano PharmaSolutions is developing remedesivir as dry powder for inhalation (DPI) formulation to make it available for everyone at early stage of infection.
NANO PHARMASOLUTIONS IN THE NEWS
Life Science Nation Interviews CEO Dr. Kay Olmstead
CEO Dr. Kay Olmstead sat down with Rory McCann of Life Science Nation to discuss Nano PharmaSolutions place in the market as well as challanges that were overcame in the [...]
Mikart and Nano PharmaSolutions have entered into a collaboration agreement:
Nano PharmaSolutions (“NPS”) has entered into a collaboration agreement with Mikart, LLC ("Mikart") a comprehensive contract development and manufacturing organization in Atlanta, GA. Read the full PR Newswire article: Here [...]
Women In Bio – NPS CEO Speaks at BIO 2022
This year Dr. Olmstead spoke at BIO International Conference representing Nano PharmaSolutions and Women in BIO. Dr. Olmstead also spoke on topics of inclusion and diversity in life science research [...]
NPS CEO to Speak at 2022 BIO International Conference
Dr. Olmstead will be speaking on a panel focusing on Health Disparity Other topics of the panel include disparities in healthcare for women, funding access, and how women founders are [...]
NPS Launches its Technology Webinar Series – Register Today
Upcoming Webinars: To be announced, thank you. Previous Webinars: Flexible Nanoformulation Early Stage Drug Development - December 16th, 2021 Rapid First in Human Nanoformulation - June 2nd, 2022